As geopolitics bring reshoring…
As geopolitics bring reshoring interest to a fever pitch, the [...]
As geopolitics bring reshoring interest to a fever pitch, the [...]
Novartis is making further workforce reductions at its U.S. headquarters [...]
Charles River Laboratories has backed an American Heart Association campaign, [...]
After more than a decade in charge of the most [...]
Japan’s Shionogi is joining the spate of drugmakers to unveil [...]
The company is moving out of the building that used [...]
Biogen has agreed to a settlement with investors who claimed [...]
With a solid year of double-digit revenue growth in the [...]
Johnson & Johnson’s immunology drug Tremfya is looking to challenge [...]
The plummeting demand for Merck’s HPV vaccine Gardasil in China [...]